ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02068365
Recruitment Status : Recruiting
First Posted : February 21, 2014
Last Update Posted : July 28, 2016
Sponsor:
Information provided by (Responsible Party):
Henry LY Chan, Chinese University of Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2020
  Study Completion Date : No date given
Publications: